Reference Pricing — Coming soon to a health plan near you?

There is great interest in reference pricing in the US for select medical procedures and branded drugs. While only 10% of mid-sized and large employers are utilizing reference pricing, more than 2/3 of employers have an interest in this payment technique. If it takes hold, there is a potential impact on utilization, revenue and quality of care that manufacturers will need to address.

Gene therapy — The price is right?

The introduction of the first gene therapy presents challenges for payers. These costly therapies will require new approaches in terms of pricing benchmarks and reimbursement methodologies.

Managed Care Musings-Tips for better payer research

Managed Care Musings-Tips for better payer research

MedSpan Research’s Managed Markets Perspectives

MedSpan Research’s Managed Markets Perspectives: Pay For Performance Programs are becoming more prevalent. Dialysis facilities are already using this type of reimbursement program to improve on quality measures.

Why Market Access is Crucial for Healthcare Marketers Today

Market access has changed dramatically over the years and is becoming a high priority for healthcare marketers. Read on to learn about these changes and how to address the complexities of gaining access.